Aditxt Finalizes $150M Ignite Proteomics Acquisition, Valued 3,600x Its Market Cap
ADTX is trading near its 52-week low of $0.046 (3.7% above the low) on elevated volume (7.6× avg).
Summary
Aditxt has signed a definitive agreement to acquire Ignite Proteomics for approximately $150 million. This valuation is a dramatic increase from the $36.475 million reported in earlier 8-K filings in March and April for the same acquisition. The $150 million valuation is roughly 3,600 times Aditxt's current market capitalization of $40,714. This acquisition is highly concerning given Aditxt's severe financial distress, including a Nasdaq delisting notice, a recent 1-for-27 reverse stock split, and substantial doubt about its ability to continue as a going concern. Ignite Proteomics was previously disclosed as a loss-making entity, making this massive acquisition even more questionable.
At the time of this announcement, ADTX was trading at $0.05 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $40.7K. The 52-week trading range was $0.05 to $53,450.61. This news item was assessed with negative market sentiment and an importance score of 10 out of 10. Source: Dow Jones Newswires.